IMPLANON (Organon USA Inc.)


Welcome to the PulseAid listing for the IMPLANON drug offered from Organon USA Inc.. This Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.




LABELER NAME / MANUFACTURER: Organon USA Inc.
NON-PROPRIETARY NAME: etonogestrel
SUBSTANCE NAME: ETONOGESTREL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Progesterone Congeners [Chemical/Ingredient],Progestin [EPC]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: IMPLANT
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-09-06
END MARKETING DATE: 0000-00-00


IMPLANON HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIMPLANON from Organon USA Inc.
LABELER NAME: Organon USA Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 68(mg/1)
START MARKETING DATE: 2011-09-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0052-0272_28d5d9d6-a604-4b37-ac4e-42fe955988fe
PRODUCT NDC: 0052-0272
APPLICATION NUMBER: NDA021529

Other ETONOGESTREL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Organon USA Inc.IMPLANON